WallStreetZenWallStreetZen

NASDAQ: CRMD
Cormedix Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CRMD

Based on 4 analysts offering 12 month price targets for Cormedix Inc.
Min Forecast
$9.00+65.44%
Avg Forecast
$13.00+138.97%
Max Forecast
$19.00+249.26%

Should I buy or sell CRMD stock?

Based on 4 analysts offering ratings for Cormedix Inc.
Strong Buy
Strong Buy
1 analysts 25%
Buy
3 analysts 75%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CRMD stock forecasts and price targets.

CRMD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-09
lockedlocked$00.00+00.00%2024-04-09
lockedlocked$00.00+00.00%2024-03-13
lockedlocked$00.00+00.00%2024-01-31

1 of 1

Forecast return on equity

Is CRMD forecast to generate an efficient return?
Company
N/A
Industry
-57.09%
Market
20.17%

Forecast return on assets

Is CRMD forecast to generate an efficient return on assets?
Company
N/A
Industry
5.72%

CRMD revenue forecast

What is CRMD's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$14.6M
Avg 2 year Forecast
$67.0M

CRMD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CRMD$5.44$13.00+138.97%Strong Buy
CDXC$3.97$6.00+51.13%Strong Buy
VRCA$7.06$10.33+46.36%Strong Buy
VNDA$5.24N/AN/A
ENTA$14.00$20.75+48.21%Hold
View Top Biotech Stocks

Cormedix Stock Forecast FAQ

Is Cormedix Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: CRMD) stock is to Strong Buy CRMD stock.

Out of 4 analysts, 1 (25%) are recommending CRMD as a Strong Buy, 3 (75%) are recommending CRMD as a Buy, 0 (0%) are recommending CRMD as a Hold, 0 (0%) are recommending CRMD as a Sell, and 0 (0%) are recommending CRMD as a Strong Sell.

If you're new to stock investing, here's how to buy Cormedix stock.

What is CRMD's revenue growth forecast for 2024-2025?

(NASDAQ: CRMD) Cormedix's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 60.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.43%.

Cormedix's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast CRMD's revenue for 2024 to be $802,724,089, with the lowest CRMD revenue forecast at $802,724,089, and the highest CRMD revenue forecast at $802,724,089.

In 2025, CRMD is forecast to generate $3,680,984,779 in revenue, with the lowest revenue forecast at $3,680,984,779 and the highest revenue forecast at $3,680,984,779.

What is CRMD's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: CRMD) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 5.72%.

What is CRMD's Price Target?

According to 4 Wall Street analysts that have issued a 1 year CRMD price target, the average CRMD price target is $13.00, with the highest CRMD stock price forecast at $19.00 and the lowest CRMD stock price forecast at $9.00.

On average, Wall Street analysts predict that Cormedix's share price could reach $13.00 by Apr 9, 2025. The average Cormedix stock price prediction forecasts a potential upside of 138.97% from the current CRMD share price of $5.44.

What is CRMD's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: CRMD) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.